General News

General News | Jul. 28, 2015

Statement on the Results of Epratuzumab Study for the Treatment of Lupus

Results from a study of epratuzumab were released today. It did not meet its primary endpoint of clinically reducing the severity of lupus in people with mild to moderate disease. The following is a statement from Sandra C. Raymond, President and CEO

General News | Jul. 15, 2015

Lupus Foundation of America’s Collaboration in PARTNERS Seeks to Improve Pediatric Research and Care

Learn more about PARTNERS (Patients, Advocates and Rheumatology Teams Network for Research and Service), a new initiative.

General News | Jul. 10, 2015

U.S. House of Representatives Passes 21st Century Cures Act

Today, the U.S. House of Representatives passed the 21st Century Cures Act, legislation that has the potential to improve the drug development process and bring new and vital treatments forward for people with chronic diseases like lupus.

General News | Jul. 09, 2015

Lupus Foundation of America Announces 2015 Awards to Support Next Generation of Lupus Investigators

These research awards seek to develop the next generation of lupus scientific leaders by fostering an interest in lupus research careers.

General News | Jun. 26, 2015

Senate Committee Answers Lupus Foundation of America’s Call for Increased Funding for Lupus Research

Statement of Sandra C. Raymond, President & CEO, Lupus Foundation of America

General News | Jun. 24, 2015

House Committee Increases Funding For Lupus Research & Education Programs

Statement of Sandra C. Raymond, President & CEO, Lupus Foundation of America

General News | Jun. 24, 2015

Dr. George C. Tsokos Receives Lupus Insight Prize at FOCIS 2015

Grant Project Aims to Improve Lupus Nephritis Treatment

General News | Jun. 17, 2015

Lupus Foundation of America Hosts Capitol Conversation on 21st Century Cures Moderated by Chuck Todd

National Advocacy Awards Dinner recognizes leaders from Congress, federal agencies, industry and the research community.